参考文献/References:
［1］Garcia-Tsao G，Abraldes JG，Berzigotti A，et al.Portal hypertensive bleeding in cirrhosis：risk stratification，diagnosis，and management：2016 practice guidance by the American Association for the Study of Liver Diseases［J］.Hepatology，2017，65：310-335.
［2］Palmaz JC，Sibbitt RR，Reuter SR，et al.Expandable intrahepatic portacaval shunt stents：early experience in the dog［J］.AJR Am J Roentgenol，1985，145：821-825.
［3］Colapinto RF，Stronell RD，Gildiner M，et al.Formation of intrahepatic portosystemic shunts using a balloon dilatation catheter：preliminary clinical experience［J］.AJR Am J Roentgenol，1983，140：709-714.
［4］Burgener FA，Gutierrez OH.Nonsurgical production of intrahepatic portosystemic venous shunts in portal hypertension with the double lumen balloon catheter （author′s transl）［J］.Rofo，1979，130：686-688.
［5］Rsch J，Hanafee W，Snow H，et al.Transjugular intrahepatic portacaval shunt.An experimental work［J］.Am J Surg，1971，121：588-592.
［6］颜志平，罗剑钧.重视经门脉系统的介入诊治［J］.介入放射学杂志，2009，18：561-562.
［7］马婧嶔，罗剑钧.“TIPS先行”的临床实践与探索［J］.肝脏，2019，24：1097-1099.
［8］Ma L，Ma J，Zhang W，et al.Acute hepatic ischemia after transjugular intrahepatic portosystemic shunt creation despite preserved arterial perfusion［J］.J Vasc Interv Radiol，2021，32：1510-1512.
［9］Kloster ML，Ren A，Shah KY，et al.High incidence of hepatic encephalopathy after viatorr controlled expansion transjugular intrahepatic portosystemic shunt creation［J］.Dig Dis Sci，2021，66：4058-4062.
［10］Perry BC，Kwan SW.Portosystemic shunts：stable utilization and improved outcomes，two decades after the transjugular intrahepatic portosystemic shunt［J］.J Am Coll Radiol，2015，12：1427-1433.
［11］Pericleous M，Sarnowski A，Moore A，et al.The clinical management of abdominal ascites，spontaneous bacterial peritonitis and hepatorenal syndrome：a review of current guidelines and recommendations［J］.Eur J Gastroenterol Hepatol，2016，28：e10-e18.
［12］European Association for the Study of the Liver.EASL clinical practice guidelines for the management of patients with decompensated cirrhosis［J］.J Hepatol，2018，69：406-460.
［13］Chinese College of Interventionalists.CCI clinical practice guidelines：management of TIPS for portal hypertension （2019 edition）［J］.Zhonghua Gan Zang Bing Za Zhi，2019，27：582-593.
［14］Tripathi D，Stanley AJ，Hayes PC，et al.Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension［J］.Gut，2020，69：1173-1192.
［15］曹家伟，丁鹏绪，段峰，等.中国门静脉高压经颈静脉肝内门体分流术临床实践指南（2019年版）［J］.临床肝胆病杂志，2019，35：2694-2699.
［16］任洪成，王斌，邵长刚，等.不同支架肝静脉端形态对经颈静脉肝内门体分流术后疗效的影响［J］.介入放射学杂志，2023，32：1001-1005.
［17］Wang XZ，Liu GF，Wu JC，et al.Small-diameter transjugular intrahepatic portosystemic shunt versus endoscopic variceal ligation plus propranolol for variceal rebleeding in advanced cirrhosis［J］.Radiology，2023，308：e223201.
［18］Yan H，Xiang Z，Zhao C，et al.6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleeding［J］.Eur Radiol，2024，34:4697-4707.
［19］Wang Q，Lv Y，Bai M，et al.Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding［J］.J Hepatol，2017，67：508-516.
［20］Trebicka J，Bastgen D，Byrtus J，et al.Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival［J］.Clin Gastroenterol Hepatol，2019，17：2793.e1-2799.e1.
［21］Borghol S，Perarnau JM，Pucheux J，et al.Short-and long-term evolution of the endoluminal diameter of underdilated stents in transjugular intrahepatic portosystemic shunt［J］.Diagn Interv Imaging，2016，97：1103-1107.
［22］Liu J，Ma J，Zhou C，et al.Potential benefits of underdilation of 8-mm covered stent in transjugular intrahepatic portosystemic shunt creation［J］.Clin Transl Gastroenterol，2021，12：e00376.
［23］Miraglia R，Maruzzelli L，Di Piazza A，et al.Transjugular intrahepatic portosystemic shunt using the new gore viatorr controlled expansion endoprosthesis：prospective，single-center，preliminary experience［J］.Cardiovasc Intervent Radiol，2019，42：78-86.
［24］Praktiknjo M，Abu-Omar J，Chang J，et al.Controlled underdilation using novel VIATORR controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation［J］.JHEP Rep，2021，3：100264.
［25］de Franchis R，Bosch J，Garcia-Tsao G，et al.Baveno Ⅶ-renewing consensus in portal hypertension［J］.J Hepatol，2022，76：959-974.
［26］Ma L，Ma J，Zhang W，et al.Predictive power of portal pressure gradient remeasured shortly after transjugular intrahepatic portosystemic shunt［J］.Hepatol Int，2023，17：417-426.
［27］Biecker E，Roth F，Heller J，et al.Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis［J］.Eur J Gastroenterol Hepatol，2007，19：846-852.
［28］Bosch J.Small diameter shunts should lead to safe expansion of the use of TIPS［J］.J Hepatol，2021，74：230-234.
［29］Ma L，Liu Y，Yan Z，et al.Comparing the predictive ability of portoatrial and portocaval gradient after transjugular intrahepatic portosystemic shunt creation for variceal rebleeding［J］.J Gastroenterol，2023，58：494-502.
［30］曹俊杰，姚志超，刘占鳌，等.个体化经颈静脉肝内门体分流术血流动力学模拟研究［J］.介入放射学杂志，2023，32：17-21.
［31］Xia Y，Tie J，Wang G，et al.Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS［J］.Hepatol Int，2023，17：967-978.
［32］Zhao D，Zhang G，Wang M，et al.Portal pressure gradient and serum albumin：a simple combined parameter associated with the appearance of ascites in decompensated cirrhosis treated with transjugular intrahepatic portosystemic shunt［J］.Clin Mol Hepatol，2019，25：210-217.
［33］Ma J，Gong X，Luo J，et al.Impact of intrahepatic venovenous shunt on hepatic venous pressure gradient measurement［J］.J Vasc Interv Radiol，2020，31：2081-2088.
相似文献/References:
[1]张书田,崔进国.经颈静脉肝内门体分流术对肝功能影响的初步研究[J].介入放射学杂志,1998,(04):220.
[2]谢苏庆,许国铭.治疗门脉高压的新途径——经颈静脉肝内门体分流术[J].介入放射学杂志,1994,(02):116.
[3]张子曙,黄祥龙,沈天真,等.经颈静脉肝内门体分流术[J].介入放射学杂志,1994,(04):239.
[4]原姗姗,韩国宏,樊代明.ＴＩＰＳ治疗门静脉高压并发症预后评价的现状[J].介入放射学杂志,2011,(03):245.
YUAN Shan-shan,HAN Guo-hong,FAN Dai-ming..TIPS treatment of the complications of portal hypertension: the current status of its prognostic evaluation [J].journal interventional radiology,2011,(10):245.
[5]安 涛,阮 娜,罗翰林,等.MRI融合导航经颈静脉肝内门体分流术的临床优势和经验[J].介入放射学杂志,2023,32(02):119.
AN Tao,RUAN Na,LUO Hanlin,et al.Transjugular intrahepatic portosystemic shunt with help of MRI fusion image navigation technique: its clinical advantages and preliminary experience[J].journal interventional radiology,2023,32(10):119.
[6]窦树彬,陆圣月.改良经颈静脉肝内门体分流术双支架植入治疗肝硬化门静脉高压临床效果[J].介入放射学杂志,2023,32(02):127.
DOU Shubin,LU Shengyue..Modified transjugular intrahepatic portosystemic shunt and double-stent implantation technique in the treatment of cirrhotic portal hypertension: analysis of its clinical effect [J].journal interventional radiology,2023,32(10):127.
[7]李如春,胡继红,潘文秋,等.TIPS治疗肝硬化伴或不伴门静脉血栓临床对比研究[J].介入放射学杂志,2024,33(10):1101.
LI Ruchun,HU Jihong,PAN Wenqiu,et al.TIPS for the treatment of cirrhosis with or without portal vein thrombosis：a comparative study[J].journal interventional radiology,2024,33(10):1101.